Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord-derived MSC exosomes for Chinese advanced AGA
NCT06697080Active, not recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jun 2024
- Primary completion
- Sep 2024
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of umbilical cord derived mesenchymal stem cells exosomes in androgenetic alopecia (AGA) (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Hair diameters changed over time at 6 months. Started Jun 2024; status: active, not recruiting.
02
Drugs
umbilical cord derived mesenchymal stem cells exosomes
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06697080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06697080.